 | • レポートコード：MRC2-11QY12380 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、95ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はインフルエンザワクチン接種のグローバル市場について調査・分析したレポートです。種類別（卵ベース、細胞培養、組換え）市場規模、用途別（病院、研究機関）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別インフルエンザワクチン接種の競争状況、市場シェア ・世界のインフルエンザワクチン接種市場：種類別市場規模 2015年-2020年（卵ベース、細胞培養、組換え） ・世界のインフルエンザワクチン接種市場：種類別市場規模予測 2021年-2026年（卵ベース、細胞培養、組換え） ・世界のインフルエンザワクチン接種市場：用途別市場規模 2015年-2020年（病院、研究機関） ・世界のインフルエンザワクチン接種市場：用途別市場規模予測 2021年-2026年（病院、研究機関） ・北米のインフルエンザワクチン接種市場分析：米国、カナダ ・ヨーロッパのインフルエンザワクチン接種市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのインフルエンザワクチン接種市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のインフルエンザワクチン接種市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのインフルエンザワクチン接種市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott (U.S.)、AstraZeneca (Europe)、BioCryst Pharmaceuticals, Inc. (U.S.)、Novartis AG (Europe)、DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)、GlaxoSmithKline plc. (Europe)、Hualan Biological Engineering Inc (Asia Pacific)、Mitsubishi Tanabe Pharma Corporation (Asia Pacific)、F. Hoffmann-La Roche Ltd (Europe)、Sanofi (Europe) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Influenza (flu) is a contagious respiratory disease caused by influenza viruses that infect the respiratory tract (nose, throat, and lungs) in humans. The symptoms and complications of flu are more severe than common cold. The symptoms associated with influenza may include fever, headache, malaise, cough, sore throat, nasal congestion, and body aches. Influenza vaccine can prevent illness and death caused
Stringent regulatory framework along with the low accessibility of the product in the developing countries may restrain the market growth.
Market Analysis and Insights: Global Influenza Vaccination Market
The global Influenza Vaccination market size is projected to reach US$ 3682.5 million by 2026, from US$ 3501.6 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Influenza Vaccination Scope and Market Size
Influenza Vaccination market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Vaccination market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott (U.S.)
AstraZeneca (Europe)
BioCryst Pharmaceuticals, Inc. (U.S.)
Novartis AG (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
GlaxoSmithKline plc. (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)
Sanofi (Europe)
Market segment by Type, the product can be split into
Egg Based
Cell Culture
Recombinant
Market segment by Application, split into
Hospitals
Research Organizations
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Influenza Vaccination Revenue
1.4 Market by Type
1.4.1 Global Influenza Vaccination Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Egg Based
1.4.3 Cell Culture
1.4.4 Recombinant
1.5 Market by Application
1.5.1 Global Influenza Vaccination Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Research Organizations
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Influenza Vaccination Market Perspective (2015-2026)
2.2 Global Influenza Vaccination Growth Trends by Regions
2.2.1 Influenza Vaccination Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Influenza Vaccination Historic Market Share by Regions (2015-2020)
2.2.3 Influenza Vaccination Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Influenza Vaccination Market Growth Strategy
2.3.6 Primary Interviews with Key Influenza Vaccination Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Influenza Vaccination Players by Market Size
3.1.1 Global Top Influenza Vaccination Players by Revenue (2015-2020)
3.1.2 Global Influenza Vaccination Revenue Market Share by Players (2015-2020)
3.1.3 Global Influenza Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Influenza Vaccination Market Concentration Ratio
3.2.1 Global Influenza Vaccination Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Influenza Vaccination Revenue in 2019
3.3 Influenza Vaccination Key Players Head office and Area Served
3.4 Key Players Influenza Vaccination Product Solution and Service
3.5 Date of Enter into Influenza Vaccination Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Influenza Vaccination Historic Market Size by Type (2015-2020)
4.2 Global Influenza Vaccination Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Influenza Vaccination Market Size by Application (2015-2020)
5.2 Global Influenza Vaccination Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Influenza Vaccination Market Size (2015-2020)
6.2 Influenza Vaccination Key Players in North America (2019-2020)
6.3 North America Influenza Vaccination Market Size by Type (2015-2020)
6.4 North America Influenza Vaccination Market Size by Application (2015-2020)
7 Europe
7.1 Europe Influenza Vaccination Market Size (2015-2020)
7.2 Influenza Vaccination Key Players in Europe (2019-2020)
7.3 Europe Influenza Vaccination Market Size by Type (2015-2020)
7.4 Europe Influenza Vaccination Market Size by Application (2015-2020)
8 China
8.1 China Influenza Vaccination Market Size (2015-2020)
8.2 Influenza Vaccination Key Players in China (2019-2020)
8.3 China Influenza Vaccination Market Size by Type (2015-2020)
8.4 China Influenza Vaccination Market Size by Application (2015-2020)
9 Japan
9.1 Japan Influenza Vaccination Market Size (2015-2020)
9.2 Influenza Vaccination Key Players in Japan (2019-2020)
9.3 Japan Influenza Vaccination Market Size by Type (2015-2020)
9.4 Japan Influenza Vaccination Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Influenza Vaccination Market Size (2015-2020)
10.2 Influenza Vaccination Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Influenza Vaccination Market Size by Type (2015-2020)
10.4 Southeast Asia Influenza Vaccination Market Size by Application (2015-2020)
11 India
11.1 India Influenza Vaccination Market Size (2015-2020)
11.2 Influenza Vaccination Key Players in India (2019-2020)
11.3 India Influenza Vaccination Market Size by Type (2015-2020)
11.4 India Influenza Vaccination Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Influenza Vaccination Market Size (2015-2020)
12.2 Influenza Vaccination Key Players in Central & South America (2019-2020)
12.3 Central & South America Influenza Vaccination Market Size by Type (2015-2020)
12.4 Central & South America Influenza Vaccination Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott (U.S.)
13.1.1 Abbott (U.S.) Company Details
13.1.2 Abbott (U.S.) Business Overview
13.1.3 Abbott (U.S.) Influenza Vaccination Introduction
13.1.4 Abbott (U.S.) Revenue in Influenza Vaccination Business (2015-2020))
13.1.5 Abbott (U.S.) Recent Development
13.2 AstraZeneca (Europe)
13.2.1 AstraZeneca (Europe) Company Details
13.2.2 AstraZeneca (Europe) Business Overview
13.2.3 AstraZeneca (Europe) Influenza Vaccination Introduction
13.2.4 AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2015-2020)
13.2.5 AstraZeneca (Europe) Recent Development
13.3 BioCryst Pharmaceuticals, Inc. (U.S.)
13.3.1 BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
13.3.2 BioCryst Pharmaceuticals, Inc. (U.S.) Business Overview
13.3.3 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Introduction
13.3.4 BioCryst Pharmaceuticals, Inc. (U.S.) Revenue in Influenza Vaccination Business (2015-2020)
13.3.5 BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
13.4 Novartis AG (Europe)
13.4.1 Novartis AG (Europe) Company Details
13.4.2 Novartis AG (Europe) Business Overview
13.4.3 Novartis AG (Europe) Influenza Vaccination Introduction
13.4.4 Novartis AG (Europe) Revenue in Influenza Vaccination Business (2015-2020)
13.4.5 Novartis AG (Europe) Recent Development
13.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
13.5.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
13.5.2 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Business Overview
13.5.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Introduction
13.5.4 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020)
13.5.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
13.6 GlaxoSmithKline plc. (Europe)
13.6.1 GlaxoSmithKline plc. (Europe) Company Details
13.6.2 GlaxoSmithKline plc. (Europe) Business Overview
13.6.3 GlaxoSmithKline plc. (Europe) Influenza Vaccination Introduction
13.6.4 GlaxoSmithKline plc. (Europe) Revenue in Influenza Vaccination Business (2015-2020)
13.6.5 GlaxoSmithKline plc. (Europe) Recent Development
13.7 Hualan Biological Engineering Inc (Asia Pacific)
13.7.1 Hualan Biological Engineering Inc (Asia Pacific) Company Details
13.7.2 Hualan Biological Engineering Inc (Asia Pacific) Business Overview
13.7.3 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Introduction
13.7.4 Hualan Biological Engineering Inc (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020)
13.7.5 Hualan Biological Engineering Inc (Asia Pacific) Recent Development
13.8 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
13.8.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
13.8.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Business Overview
13.8.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Introduction
13.8.4 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020)
13.8.5 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
13.9 F. Hoffmann-La Roche Ltd (Europe)
13.9.1 F. Hoffmann-La Roche Ltd (Europe) Company Details
13.9.2 F. Hoffmann-La Roche Ltd (Europe) Business Overview
13.9.3 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Introduction
13.9.4 F. Hoffmann-La Roche Ltd (Europe) Revenue in Influenza Vaccination Business (2015-2020)
13.9.5 F. Hoffmann-La Roche Ltd (Europe) Recent Development
13.10 Sanofi (Europe)
13.10.1 Sanofi (Europe) Company Details
13.10.2 Sanofi (Europe) Business Overview
13.10.3 Sanofi (Europe) Influenza Vaccination Introduction
13.10.4 Sanofi (Europe) Revenue in Influenza Vaccination Business (2015-2020)
13.10.5 Sanofi (Europe) Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Influenza Vaccination Key Market Segments
Table 2. Key Players Covered: Ranking by Influenza Vaccination Revenue
Table 3. Ranking of Global Top Influenza Vaccination Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Influenza Vaccination Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Egg Based
Table 6. Key Players of Cell Culture
Table 7. Key Players of Recombinant
Table 8. Global Influenza Vaccination Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Influenza Vaccination Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Influenza Vaccination Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Influenza Vaccination Market Share by Regions (2015-2020)
Table 12. Global Influenza Vaccination Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Influenza Vaccination Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Influenza Vaccination Market Growth Strategy
Table 18. Main Points Interviewed from Key Influenza Vaccination Players
Table 19. Global Influenza Vaccination Revenue by Players (2015-2020) (Million US$)
Table 20. Global Influenza Vaccination Market Share by Players (2015-2020)
Table 21. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccination as of 2019)
Table 22. Global Influenza Vaccination by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Influenza Vaccination Product Solution and Service
Table 25. Date of Enter into Influenza Vaccination Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 28. Global Influenza Vaccination Market Size Share by Type (2015-2020)
Table 29. Global Influenza Vaccination Revenue Market Share by Type (2021-2026)
Table 30. Global Influenza Vaccination Market Size Share by Application (2015-2020)
Table 31. Global Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 32. Global Influenza Vaccination Market Size Share by Application (2021-2026)
Table 33. North America Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Influenza Vaccination Market Share (2019-2020)
Table 35. North America Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 36. North America Influenza Vaccination Market Share by Type (2015-2020)
Table 37. North America Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 38. North America Influenza Vaccination Market Share by Application (2015-2020)
Table 39. Europe Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Influenza Vaccination Market Share (2019-2020)
Table 41. Europe Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Influenza Vaccination Market Share by Type (2015-2020)
Table 43. Europe Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Influenza Vaccination Market Share by Application (2015-2020)
Table 45. China Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 46. China Key Players Influenza Vaccination Market Share (2019-2020)
Table 47. China Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 48. China Influenza Vaccination Market Share by Type (2015-2020)
Table 49. China Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 50. China Influenza Vaccination Market Share by Application (2015-2020)
Table 51. Japan Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Influenza Vaccination Market Share (2019-2020)
Table 53. Japan Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Influenza Vaccination Market Share by Type (2015-2020)
Table 55. Japan Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Influenza Vaccination Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Influenza Vaccination Market Share (2019-2020)
Table 59. Southeast Asia Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Influenza Vaccination Market Share by Type (2015-2020)
Table 61. Southeast Asia Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Influenza Vaccination Market Share by Application (2015-2020)
Table 63. India Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 64. India Key Players Influenza Vaccination Market Share (2019-2020)
Table 65. India Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 66. India Influenza Vaccination Market Share by Type (2015-2020)
Table 67. India Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 68. India Influenza Vaccination Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Influenza Vaccination Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Influenza Vaccination Market Share (2019-2020)
Table 71. Central & South America Influenza Vaccination Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Influenza Vaccination Market Share by Type (2015-2020)
Table 73. Central & South America Influenza Vaccination Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Influenza Vaccination Market Share by Application (2015-2020)
Table 75. Abbott (U.S.) Company Details
Table 76. Abbott (U.S.) Business Overview
Table 77. Abbott (U.S.) Product
Table 78. Abbott (U.S.) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 79. Abbott (U.S.) Recent Development
Table 80. AstraZeneca (Europe) Company Details
Table 81. AstraZeneca (Europe) Business Overview
Table 82. AstraZeneca (Europe) Product
Table 83. AstraZeneca (Europe) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 84. AstraZeneca (Europe) Recent Development
Table 85. BioCryst Pharmaceuticals, Inc. (U.S.) Company Details
Table 86. BioCryst Pharmaceuticals, Inc. (U.S.) Business Overview
Table 87. BioCryst Pharmaceuticals, Inc. (U.S.) Product
Table 88. BioCryst Pharmaceuticals, Inc. (U.S.) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 89. BioCryst Pharmaceuticals, Inc. (U.S.) Recent Development
Table 90. Novartis AG (Europe) Company Details
Table 91. Novartis AG (Europe) Business Overview
Table 92. Novartis AG (Europe) Product
Table 93. Novartis AG (Europe) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 94. Novartis AG (Europe) Recent Development
Table 95. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Company Details
Table 96. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Business Overview
Table 97. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Product
Table 98. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 99. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Recent Development
Table 100. GlaxoSmithKline plc. (Europe) Company Details
Table 101. GlaxoSmithKline plc. (Europe) Business Overview
Table 102. GlaxoSmithKline plc. (Europe) Product
Table 103. GlaxoSmithKline plc. (Europe) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 104. GlaxoSmithKline plc. (Europe) Recent Development
Table 105. Hualan Biological Engineering Inc (Asia Pacific) Company Details
Table 106. Hualan Biological Engineering Inc (Asia Pacific) Business Overview
Table 107. Hualan Biological Engineering Inc (Asia Pacific) Product
Table 108. Hualan Biological Engineering Inc (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 109. Hualan Biological Engineering Inc (Asia Pacific) Recent Development
Table 110. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Business Overview
Table 111. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Product
Table 112. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Company Details
Table 113. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 114. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Recent Development
Table 115. F. Hoffmann-La Roche Ltd (Europe) Company Details
Table 116. F. Hoffmann-La Roche Ltd (Europe) Business Overview
Table 117. F. Hoffmann-La Roche Ltd (Europe) Product
Table 118. F. Hoffmann-La Roche Ltd (Europe) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 119. F. Hoffmann-La Roche Ltd (Europe) Recent Development
Table 120. Sanofi (Europe) Company Details
Table 121. Sanofi (Europe) Business Overview
Table 122. Sanofi (Europe) Product
Table 123. Sanofi (Europe) Revenue in Influenza Vaccination Business (2015-2020) (Million US$)
Table 124. Sanofi (Europe) Recent Development
Table 125. Research Programs/Design for This Report
Table 126. Key Data Information from Secondary Sources
Table 127. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Influenza Vaccination Market Share by Type: 2020 VS 2026
Figure 2. Egg Based Features
Figure 3. Cell Culture Features
Figure 4. Recombinant Features
Figure 5. Global Influenza Vaccination Market Share by Application: 2020 VS 2026
Figure 6. Hospitals Case Studies
Figure 7. Research Organizations Case Studies
Figure 8. Influenza Vaccination Report Years Considered
Figure 9. Global Influenza Vaccination Market Size YoY Growth 2015-2026 (US$ Million)
Figure 10. Global Influenza Vaccination Market Share by Regions: 2020 VS 2026
Figure 11. Global Influenza Vaccination Market Share by Regions (2021-2026)
Figure 12. Porter's Five Forces Analysis
Figure 13. Global Influenza Vaccination Market Share by Players in 2019
Figure 14. Global Top Influenza Vaccination Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Vaccination as of 2019
Figure 15. The Top 10 and 5 Players Market Share by Influenza Vaccination Revenue in 2019
Figure 16. North America Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. Europe Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. China Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Japan Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Southeast Asia Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. India Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Central & South America Influenza Vaccination Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Bottom-up and Top-down Approaches for This Report
Figure 24. Data Triangulation
Figure 25. Key Executives Interviewed
ワクチン・予防接種の世界市場（～2026年） Vaccination is the administration of antigenic material (avaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. The increasing popularity of pediatric, travel, addiction, and pediatric combination vaccin…- インフルエンザ診断の世界市場（～2026年） Influenza is an infectious disease and affects the upper respiratory tract in humans. The disease is common in children and elderly population (aged 65 years and above). The disease has a huge impact on Public Company health. Influenza A virus poses a greater risk as compared to the influenza B viru…
- 犬用インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Canine Influenza Vaccine Market The global Canine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Canine Influenza Vaccine Scope and Market Size Canine Influenza V…
- 馬インフルエンザワクチンの世界市場（～2026年） Market Analysis and Insights: Global Equine Influenza Vaccine Market The global Equine Influenza Vaccine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Equine Influenza Vaccine Scope and Market Size Equine Influenza V…
- インフルエンザ治療薬の世界市場（～2026年） Influenza medication includes antiviral drugs prescribed for the treatment of influenza. Influenza, also known as flu, is a respiratory disease caused by an influenza virus. It is a viral infectious disease that includes three major types: type A, type B, and type C. The common symptoms of the disor…